COST-EFFECTIVENESS OF ALIROCUMAB FOR MYOCARDIAL INFARCTION IN CHINA

被引:0
|
作者
Liang, Z. [1 ]
Chen, Q. [2 ]
Zhao, Q. [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Dept Cardiol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Anzhen Hosp, Sleep Med Ctr, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P612
引用
收藏
页码:E252 / E252
页数:1
相关论文
共 50 条
  • [31] Cost-effectiveness of primary prevention of myocardial infarction using statins in Germany
    Lauterbach, KW
    Danner, M
    ATHEROSCLEROSIS XI, 1998, 1155 : 933 - 939
  • [32] THE COST-EFFECTIVENESS OF MYOCARDIAL REVASCULARIZATION
    COLES, JG
    COLES, JC
    CANADIAN JOURNAL OF SURGERY, 1982, 25 (02) : 123 - 126
  • [33] Cost-Effectiveness of Optimal Use of Acute Myocardial Infarction Treatments and Impact on Coronary Heart Disease Mortality in China
    Wang, Miao
    Moran, Andrew E.
    Liu, Jing
    Coxson, Pamela G.
    Heidenreich, Paul A.
    Gu, Dongfeng
    He, Jiang
    Goldman, Lee
    Zhao, Dong
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2014, 7 (01): : 78 - 85
  • [34] Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China
    Yuansheng Wan
    Jinyu Liu
    Xiaolian Zhan
    Yu Zhang
    Ruxu You
    Cost Effectiveness and Resource Allocation, 21
  • [35] Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China
    Wan, Yuansheng
    Liu, Jinyu
    Zhan, Xiaolian
    Zhang, Yu
    You, Ruxu
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2023, 21 (01)
  • [36] COST-EFFECTIVENESS OF IMPROVING ACUTE MYOCARDIAL INFARCTION TREATMENTS AND THE IMPACT ON MORTALITY RATE OF CORONARY HEART DISEASE IN CHINA
    Miao, Wang
    Moran, Andrew
    Liu, Jing
    Coxson, Pamela
    Heidenreich, Paul
    Gu, Dongfeng
    He, Jiang
    Goldman, Lee
    Zhao, Dong
    HEART, 2013, 99 : E127 - E127
  • [37] Projected Cost-effectiveness of Smoking Cessation Interventions in Patients Hospitalized With Myocardial Infarction
    Ladapo, Joseph A.
    Jaffer, Farouc A.
    Weinstein, Milton C.
    Froelicher, Erika Sivarajan
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (01) : 39 - 45
  • [38] Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction
    Thokala, Praveen
    Goodacre, Steve W.
    Collinson, Paul O.
    Stevens, John W.
    Mills, Nicholas L.
    Newby, David E.
    Morris, Francis
    Kendall, Jason
    Stevenson, Matt D.
    HEART, 2012, 98 (20) : 1498 - 1503
  • [39] Comparative Cost-Effectiveness of Interventions to Improve Medication Adherence after Myocardial Infarction
    Ito, Kouta
    Shrank, William
    Avorn, Jerry
    Patrick, Amanda
    Brennan, Troyen
    Antman, Elliott
    Choudhry, Niteesh
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 17 - 17
  • [40] Polypill for secondary prevention of myocardial infarction: Cost-effectiveness analysis in the German setting
    Barth C.
    Diekmann S.
    Neusser S.
    Bramlage P.
    Wasem J.
    Neumann A.
    Der Kardiologe, 2017, 11 (6): : 473 - 479